Search
GSK plc
GSKAdd to Watchlist
50.665USD
-0.415-0.81%
Market hours 09/22, 13:39（ET）
103.24BMarket Cap
13.06P/E TTM
GSK plc (GSK) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to GSK plc in the past month.
Buy
2 Strong Buy
3 Buy
4 Hold
1 Sell
0 Strong Sell
Target Price
55.287USD+10.09%
GSK Analyst Recommendation Trends
In the current month, GSK has received 3 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. GSK average Analyst price target in the last month is 55.287.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
1
2
2
2
2
2
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
10
10
9
10
10
10
10
10
GSK Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Amgen Inc
AMGN
4
12
18
2
1
37
Biogen Inc
BIIB
7
17
12
1
0
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, GSK EPS is projected to reach 1.434 in FY2026Q3, following reported EPS of 0.291 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.67
1.16
1.25
1.43
0.78
Actual
0.42
1.16
0.29
--
--
Surprise
-36.93%
+0.07%
-76.81%
--
--
FAQs
What is GSK plc's expected revenue for the next quarter?
GSK plc's expected revenue is 11.93B.
What is GSK plc's price target?
Analysts forecast that GSK plc's price target is USD 55.29, with the highest forecast at USD 67.40 and the lowest forecast at USD 37.25.
How have GSK plcGSK's recent earnings per share performed?
The market expectation was USD 0.29, while GSK plcGSK's earnings per share (EPS) for the previous quarter was USD 1.16. EPS for the next quarter is expected at USD 1.43.
What is the analyst rating for GSK plc?
Based on the ratings of GSK plc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.